FCE News https://fcenews.it/index.php 2016-06-21T22:42:12Z Joomla! 1.5 - Open Source Content Management Could restoring electrical signals help heal diabetic wounds 2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211402:could-restoring-electrical-signals&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected] DermatologiaMouse study finds cornea wounds in diabetes have abnormal electric signals and suggests they could be a target in managing slow and non-healing wounds. ... ... DermatologiaMouse study finds cornea wounds in diabetes have abnormal electric signals and suggests they could be a target in managing slow and non-healing wounds. ... ... Possible psoriasis drug target identified by Stanford researchers 2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211403:possible-psoriasis-drug-target&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected] DermatologiaPsoriasis is one of the most common human skin diseases. People with severe cases sometimes resort to immunosuppressive treatment to quell the skin scaling, itching and joint arthritis that are... ... ... DermatologiaPsoriasis is one of the most common human skin diseases. People with severe cases sometimes resort to immunosuppressive treatment to quell the skin scaling, itching and joint arthritis that are... ... ... New drug clears psoriasis in clinical trials 2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211404:drug-clears-psoriasis-clinical&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected] DermatologiaAbout 80 percent of patients with moderate to severe psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab, according to three large, long-term... ... ... DermatologiaAbout 80 percent of patients with moderate to severe psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab, according to three large, long-term... ... ... Lignin from plants boosts the effectiveness of sunscreen 2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211405:lignin-from-plants-boosts&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected] DermatologiaWarm weather means beach vacations and pool-dipping for many of us. It also signals a season of slathering on sunscreen to avoid getting burned. ... ... DermatologiaWarm weather means beach vacations and pool-dipping for many of us. It also signals a season of slathering on sunscreen to avoid getting burned. ... ... Stem cells from umbilical cord blood may help treat eczema 2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211406:stem-cells-from-umbilical&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected] DermatologiaA new study suggests that treatment with stem cells from umbilical cord blood might be an effective therapy for patients with moderate-to-severe eczema, or atopic dermatitis. ... ... DermatologiaA new study suggests that treatment with stem cells from umbilical cord blood might be an effective therapy for patients with moderate-to-severe eczema, or atopic dermatitis. ... ... Early detection, smaller cancer among benefits of skin cancer screening at primary care visits 2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211407:early-detection-smaller-cancer&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected] DermatologiaSkin cancer screenings performed by primary care physicians (PCPs) during routine office visits improve the detection of potentially deadly melanomas and find them in earlier stages, according to... ... ... DermatologiaSkin cancer screenings performed by primary care physicians (PCPs) during routine office visits improve the detection of potentially deadly melanomas and find them in earlier stages, according to... ... ... Investigational immunotherapy drug well tolerated in those with rare form of melanoma 2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211408:investigational-immunotherapy-drug-well&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected] DermatologiaAn investigational immunotherapy drug being tested in the treatment of a rare form of skin cancer known as Merkel cell carcinoma has been found to be well tolerated with a clinical benefit seen in... ... ... DermatologiaAn investigational immunotherapy drug being tested in the treatment of a rare form of skin cancer known as Merkel cell carcinoma has been found to be well tolerated with a clinical benefit seen in... ... ... Confocal microscopy effective in analyzing infestation of mites in human skin disease 2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211409:confocal-microscopy-effective-analyzing&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected] DermatologiaIn the diagnosis of skin conditions caused by parasitic mites, a recent research study has outlined distinct advantages in the use of confocal microscope over the usual light microscope. ... ... DermatologiaIn the diagnosis of skin conditions caused by parasitic mites, a recent research study has outlined distinct advantages in the use of confocal microscope over the usual light microscope. ... ... Atopic dermatitis: Positive topline Phase 3 results announced for dupilumab 2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211410:atopic-dermatitis-positive-topline&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected] DermatologiaRegeneron Pharmaceuticals, Inc. and Sanofi have announced that a one-year Phase 3 study, known as LIBERTY AD CHRONOS, evaluating investigational dupilumab met its primary and key secondary... ... ... DermatologiaRegeneron Pharmaceuticals, Inc. and Sanofi have announced that a one-year Phase 3 study, known as LIBERTY AD CHRONOS, evaluating investigational dupilumab met its primary and key secondary... ... ... Nanoparticle sunscreens effective and safe to use 2016-06-21T08:00:00Z 2016-06-21T08:00:00Z https://fcenews.it/index.php?option=com_content&view=article&id=211411:nanoparticle-sunscreens-effective-safe&catid=1011:dermatologia&Itemid=133 Dermatology News From Medical News Today [email protected] DermatologiaThere has been public concern about the safety of nanoparticle sunscreens, but the available evidence indicates that they are both effective and safe to use, according to a Perspective published in... ... ... DermatologiaThere has been public concern about the safety of nanoparticle sunscreens, but the available evidence indicates that they are both effective and safe to use, according to a Perspective published in... ... ...